Petra is a pharmaceutical company dedicated to discovering and developing novel therapies that modulate phosphoinositide (PI) signaling pathways for the treatment of cancer and other serious diseases.
PI pathways regulate fundamental processes of cellular growth and metabolism. The importance of PI signaling in human health is underscored by the many diseases that arise from PI pathway deregulation. PI-modifying enzymes are among the most frequently mutated proteins in cancer.
We are committed to advancing the promise of PI signaling pathways to generate important and novel therapies for unaddressed medical needs.